PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,767,046 | -2.9% | 4,033,721 | -1.0% | 0.00% | 0.0% |
Q2 2023 | $25,512,656 | +33.6% | 4,075,504 | +1.8% | 0.00% | +50.0% |
Q1 2023 | $19,094,000 | +53474.6% | 4,002,884 | -2.3% | 0.00% | -60.0% |
Q4 2022 | $35,640 | -99.9% | 4,096,551 | -13.0% | 0.01% | -37.5% |
Q3 2022 | $56,003,000 | -20.1% | 4,706,099 | -4.3% | 0.01% | -20.0% |
Q2 2022 | $70,100,000 | +5.0% | 4,919,323 | +53.5% | 0.01% | +25.0% |
Q1 2022 | $66,739,000 | -8.8% | 3,205,487 | +1.2% | 0.01% | 0.0% |
Q4 2021 | $73,164,000 | +35.9% | 3,167,222 | +75.3% | 0.01% | +14.3% |
Q3 2021 | $53,852,000 | -4.1% | 1,807,092 | +10.0% | 0.01% | 0.0% |
Q2 2021 | $56,127,000 | +82.4% | 1,643,064 | +75.7% | 0.01% | +75.0% |
Q1 2021 | $30,765,000 | +1248.2% | 935,390 | +2421.3% | 0.00% | – |
Q4 2020 | $2,282,000 | +500.5% | 37,099 | +271.0% | 0.00% | – |
Q3 2020 | $380,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $19,217,000 | 59.24% |
Euclidean Capital LLC | 2,336,909 | $27,809,000 | 25.82% |
OUP Management Co., LLC | 989,232 | $11,772,000 | 18.33% |
Nextech Invest Ltd. | 1,385,807 | $16,491,000 | 5.33% |
Boxer Capital, LLC | 3,163,795 | $37,649,000 | 2.12% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $6,549,000 | 1.64% |
Orbimed Advisors | 6,563,077 | $78,101,000 | 1.45% |
RTW INVESTMENTS, LP | 4,356,920 | $51,847,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 154,500 | $1,839,000 | 0.79% |
Monarch Partners Asset Management LLC | 210,370 | $2,503,000 | 0.75% |